Pharmaceutical computational chemists leverage advanced computational techniques and molecular modeling tools to accelerate drug discovery and development. By simulating molecular interactions, predicting chemical properties, and designing novel compounds, they help identify promising drug candidates before costly laboratory synthesis and testing. These scientists use methods such as molecular docking, quantum mechanics, and molecular dynamics to understand the behavior of drug molecules and their targets at the atomic level. Their work significantly reduces the time and cost associated with bringing new medications to market, improving efficiency in pharmaceutical research.
Pharmaceutical computational chemists analyze the pharmacokinetics and toxicity profiles of compounds using in silico models, helping to predict how drugs will behave in the human body. They collaborate closely with medicinal chemists, biologists, and pharmacologists to optimize drug candidates and guide experimental efforts. As artificial intelligence and machine learning technologies advance, computational chemists increasingly integrate these tools to enhance predictive accuracy and streamline drug development pipelines. Their expertise is crucial in bridging theoretical chemistry and practical application, driving innovation and improving the success rate of new therapeutic agents. Their contributions are pivotal in shaping the future of personalized medicine and targeted therapies. Furthermore, their work supports the pharmaceutical industry’s efforts to meet evolving regulatory requirements and market demands.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada